Kelly Chibale PhD
University of Cape Town
Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT). He is also a Full Member of the UCT Institute of Infectious Disease & Molecular Medicine, a Tier 1 South Africa Research Chair in Drug Discovery, founding Director of the South African Medical Research Council (SAMRC) Drug Discovery and Development Research Unit at UCT and the Founder and Director of the UCT Drug Discovery and Development Centre (H3D).
Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK (1989-1992). This was followed by postdoctoral stints at the University of Liverpool in the UK (1992-94) and at the Scripps Research Institute in the USA (1994-96). He was a Sandler Sabbatical Fellow at the University of California San Francisco (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine (2008) and a Visiting Professor at Pfizer in the UK (2008).
Appearances
DateJune 5, 2019_DRUG DISCOVERY RESEARCH IN AFRICA HAS LAGGED BEHIND THAT CARRIED OUT IN THE MORE DEVELOPED NATIONS OF THE WORLD._ Africa is often described as the “next frontier” in the global economy, yet a crippling disease burden continues to choke economic growth on the continent…Moderator
Kelly Chibale, PhDUniversity of Cape TownSpeakers
Greg Basarab, PhDUniversity of Cape TownSusan Winks, PhDUniversity of Cape TownJames Duffy, PhDMedicines for Malaria VenturePeter Warner, PhDBill & Melinda Gates FoundationZoleka Ngcete, MSSouth African Medical Research CouncilFreeStandard Price
